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Résumé 
Ce travail de thèse a été réalisé au sein de l'Unité de Thérapie Génique et Biologie des Cellules 
Souches de l'Hôpital Jules- Gonin dans le Service d'Ophtalmologie de l'Université de Lausanne. Ce 
laboratoire recherche des solutions thérapeutiques pour des maladies dégénératives et incurables de la 
rétine comme les rétinites pigmentaires (RP). Ayant déjà montré certains résultats dans le domaine, la 
thérapie génique a été notre outil pour ce travail. Cette méthode se base sur le principe de remplacer un 
gène déficient par sa copie normale, en transportant celle-ci au cœur même du noyau par un vecteur. Il 
existe à l'heure actuelle différents vecteurs. Un des plus efficaces est un vecteur viral non-réplicatif: le 
lentivirus, dérivé de HIV-1. Celui-ci a la capacité d'intégrer le génome de la cellule cible, lui conférant 
ainsi un nouveau matériel génétique. 
Notre but a été d'établir le tropisme du lentivirus dans une rétine en dégénérescence. Ce lentivirus est 
connu pour transduire efficacement les cellules de l'épithélium pigmentaire rétinien dans l'œil adulte 
sain, ainsi que celles de la neurorétine, mais ce, uniquement durant le développement. On sait aussi 
que le vecteur lentiviral présente un tropisme différent selon les enveloppes dont il est muni ; par 
exemple, le lentivirus avec une enveloppe Mokola est connu pour transduire les cellules gliales du 
système nerveux central. La rétine qui dégénère montre quant à elle des changements de sa structure 
qui pourraient influencer la diffusion du vecteur et/ou son tropisme. 
Le postulat de base a été le suivant : chez l'adulte, la transduction des neurones de la rétine via le 
lentivirus pourrait être facilitée par l'altération de la membrane limitante externe induite par la 
dégénérescence (meilleure pénétrance du virus). 
D'un point de vue technique, nous avons utilisé deux types distincts de modèles murins de 
dégénérescence rétinienne : des souris Balb/C soumises à une dose toxique de lumière et les souris 
Rhodopsin knockout, animaux génétiquement modifiés. Comme vecteur viral, nous avons employé 
deux différents pseudotypes de lentivirus (caractérisés par les enveloppes virales) avec différents 
promoteurs (séquence d' ADN qui initie la transduction et confère la spécificité d'expression d'un 
gène). En changeant l'enveloppe et le promoteur, nous avons essayé de trouver la meilleure 
combinaison pour augmenter l'affinité du vecteur vis-à-vis des photorécepteurs d'abord, puis vis-à-vis 
d'autres cellules de la rétine. 
Nos résultats ont montré que la membrane limitante externe est effectivement altérée chez les deux 
modèles de dégénérescence, mais que cette modification ne favorise pas la transduction des 
photorécepteurs lorsqu'on utilise un vecteur lentiviral contenant une enveloppe VSVG et un 
promoteur photorécepteur-spécifique ou ubiquitaire. En effet, une forte réaction gliale a été observée. 
Par contre, en utilisant le lentivirus avec une enveloppe Mokola et un promoteur ubiquitaire, nous 
avons constaté une très bonne transduction au niveau des cellules de Müller dans la rétine en 
dégénérescence, phénomène non observé chez les souris sauvages. 
Ce travail a donc permis de trouver un vecteur viral efficace pour atteindre et transduire les cellules de 
Müller, ceci seulement pendant la dégénérescence de la rétine. Ces cellules, une fois transduites, 
pourraient être utilisées pour sécréter dans la rétine des agents thérapeutiques tels que des facteurs 
neurotrophiques pour soutenir la survie des photorécepteurs ou des facteurs anti-angiogéniques pour 
prévenir la néo-vascularisation lors de diabète ou de dégénérescence maculaire liée à l'âge. 
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Abstract 
ln normal mice, the lentiviral vector (LV) is very efficient to target the RPE cells, but transduces retinal neurons well only 
during development. ln the present study, the tropism of LV has been investigated in the degenerating retina of mice, 
knowing that the retina structure changes during degeneration. We postulated that the viral transduction would be 
increased by the alteratîon of the outer limiting membrane (OLM). Two different LV pseudotypes were tested using the 
VSVG and the Mokola envelopes, as well as two animal models of retinal degeneration: light-damaged Balb-C and 
Rhodopsin knockout (Rho-/-) mice. After light damage, the OLM is altered and no significant increase of the number of 
transduced photoreceptors can be obtained with a LV-VSVG-Rhop-GFP vector. ln the Rho-/- mice, an alteration of the OLM 
was also observed, but the possibility of transducing photoreceptors was decreased, probably by ongoing gliosis. The use 
of a ubiquitous promoter allows better photoreceptor transduction, suggesting that photoreceptor-specific promoter 
activity changes during late stages of photoreceptor degeneration. However, the number of targeted photoreceptors 
remains low. ln contrast, LV pseudotyped with the Mokola envelope allows a wide dispersion of the vector into the retina 
(corresponding to the injection bleb) with preferential targeting of Müller cells, a situation which does not occur in the wild-
type retina. Mokola-pseudotyped lentiviral vectors may serve to engineer these glial cells to deliver secreted therapeutic 
factors to a diseased area of the retina. 
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Introduction 
Research in gene therapy for eye diseases has become 
increasingly interesting with the development of vectors efficient 
in targeting different ce!! types of the retina or the cornea. Arnong 
different vector families, the AA V vectors and the lentiviral vectors 
are widely used for either a gene replacement or a neuroprotective 
strategy. Depending on the serotype, AA V vectors can preferen-
tially target the retinal pigmented epithelium (RPE[l ,2]), or 
photoreceptors[3,4], whereas lentiviral vectors predominantly 
transduce the RPE cells[5,6] and Müller cells at the injection 
site [7]. AA V-based gene therapy has shown many successes in 
gene replacement treatments for animal models of autosomal 
inherited retinal degeneration[S], whereas the HIVl-derived 
lentiviral vectors (LVs) were efficient against diseases affecting 
the RPE[l,9-11], in retinal ganglion cells when injured[12], and 
in photoreceptors when the cells are targeted early during 
development[l3]. Indeed, the HIVl-derived lentiviral vector can 
target photoreceptors just after birth and some days la ter when no 
physical barrier is formed yet between the RPE and the 
photoreceptors, and, between photoreceptors themselves [14]. 
The equine lentiviral vector seems to have the same behaviour, 
with a slightly increased capacity to transduce photorecep-
tors [15, 16], still improved using the Rabbies-G envelope[15]. 
··®··. .. 
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l\1ost of the studies on vector tropism were undertaken in 
normal retinas or at an early stage of retinal degeneration and little 
is known concerning the ability of the vectors to transduce retinal 
cells at advanced stages of retinal degeneration. During disease 
progression, the retina undergoes a major structural remodelling, 
thus creating a different environment that may impact vector 
diffusion and transduction capabilities. Indeed, the retina shows 
important changes in neurons[l 7,18] and glia such as gliosis, 
rupture of the outer limiting membrane[19,20] (OLM), cell loss, 
and remodelling of synaptic connexions (for review[21]). These 
retinal modifications were mainly studied with the goal of 
improving ce!! integration after transplantation into the retina. 
Cel! transplantation studies revealed that the OLM and extracel-
lular matrix proteins impair the passage of cells from the subretinal 
space towards the inner retina [22,23]. For instance, the Joss of the 
Crumb protein which participates to the cohesion of the OLM, 
facilitates the migration of transplanted primary retinal cells into 
the outer nuclear layer[22]. Concerning gene transfer, a recent 
interesting work shows that, after intravitreal injection, a Cy3-
labelled-AA V vector diffuses into the retina of a rat mode! of 
retinal degeneration, whereas no diffusion into this tissue was 
observed in wild-type animais. l\foreover, cells of ail layers, 
including photoreceptors can be targeted, the efficiency remaining 
August 2011 1 Volume 6 1 Issue 8 1 e23782 
to be improved. This study shows the possibility to target retinal 
cells, when the structural change of the inner-limiting membrane 
occurs during retinal disease, [24]. 
Hypothesizing that the structural remodelling taking place 
during the course of retinal degeneration could limit the barrier 
mechanism, we have investigated in the present study whether 
HIVI-derived lentiviral vectors have a capacity to diffuse through 
retinal layers and transduce various cell types when injected into 
degenerating retinas. \1\le focused our study on two different 
animal models ofphotoreceptor loss, one acutely induced, the light 
damage mode!, the other modelling an inherited disease, the 
Rhodopsin knockout mouse (Rho-/-). These experiments were 
performed using HIV 1-derived vectors pseudotyped with the 
pantropic vesicular stomatitis virus glycoprotein (VSV-G) or the 
Lyssavirus Mokola glycoprotein (l\fok-G) previously shown to 
preferentially target glial cells in the central nervous system[25]. 
Results 
To investigate whether the lentiviral vector (LV) targets the 
neuroretina better during retinal degeneration, we first examined 
the integrity of the OLM in an acute mode! of retinal 
degeneration, the light damage mode!. Mice were submitted to 
5000 lux during one hour and the retina fixed 36 hours later, at 
the apoptosis peak, for immunohistochemistry investigation. Zona-
occludin-1 (Z0-1) is a major component stabilizing the structure 
of adherent junctions and was shown to be altered in certain 
neurodegenerative processes including the Rhodopsin knockout 
(Rho-/-) mouse[l9,20]. Z0-1 participates to tightjunctions as well 
as adherent junctions and, with the help of other members of the 
cadherin, catenin and occludin family members, forms a hermetic 
barrier at the OLM level. These proteins are deregulated in the 
Rho-/- retina [19,20]. In control mice, a linear continuous labelling 
of Z0-1 can be observed at the level of the OLM (Figure 1 a). In 
mice subjected to light damage, several disruptions of the Z0-1 
linear staining are evident in the central part of the retina with a 
reduced expression (Figure 1 b ), but not in the periphery where no 
toxic effects occur. 
In consequence, in order to assess the influence of these 
structural remodellings of the retina on lentiviral transduction and 
diffusion, we injected groups of mice 36 hours after light damage 
with a LV driving the expression of GFP under the Rhodopsin 
promoter and pseudotyped with a VSVG envelope (LV-VSVG-
Rhop-GFP) to first investigate whether the photoreceptors can be 
targeted in this mode!. The number of GFP-positive photorecep-
tors per slice was counted 7 days later. No significant differences 
were observed between groups (Figure 1 c and d, controls: 
71±37.5 and light damage: 71±22.5 GFP cells/200 µm, n=4 
and 6 respectively). The rapid loss of outer segments and 
photoreceptors after the light damage induction may be in part 
responsible for the impaired efficacy of LV penetration into the 
ONL in this mode!. A constant loss of photoreceptors during the 
first days after light damage may have eliminated the cells that 
were preferentially transduced after the OLl'vI rupture. Vve also 
investigated whether the OLM was reinforced by a Müller cell 
process (explaining the poor vector diffusion), but no glial cell 
reaction at the ONL level was observed 36 !murs after light 
damage (data not shown). 
Vif e then decided to test the same vector in an animal mode! of 
slow retinal degeneration process to avoid the problem of rapid 
photoreceptor loss. The vector diffusion and transduction capacity 
was investigated in young adults as well as more mature Rfzodopsin 
knockout mice (Rfzo-1-), which have no phototransduction in their 
rods and show a rod loss starting at around one month. The 
··~· '. .. 
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integrity of the OLM was first investigated, previous results having 
already reported alteration of the Z0-1 localization in the Rho-/-
mouse[l 9,20]. At 1 and 1.4 rnonths of age, the retinas of the 
Rho-/- and wild type controls show no differences respectively, 
whereas few alterations of the Z0-1 structure can be detected at 
2.4 months (Figure 2e). At 4.9 months in Rfw-1- retinas, Z0-1 
labelling presents a multitude of discontinuous regions revealing a 
profound change of the OLM structure (Figure 2f). These results 
confirm previous observations[19] also showing that the integrity 
of the OLM is altered in this mode!, although in our hands the 
Rfzo-1- retinas show a delayed alteration of Z0-1 distribution in 
the OLM. Nonetheless, our results confirrn that the OLM barrier 
is partially modified, potentially allowing a better diffusion of 
lentiviral vectors when injected subretinally. To test this hypothesis 
and to reveal transduced photoreceptors, the LV-VSVG-Rhop-
GFP was injected into young adults (! month old), before the 
disruption of the Z0-1 expression, and advanced-stage (4.9 
months old) Rho-/- mice, when the OLJ\1 structure is altered, as 
well as in age-rnatched wild type C5 7 /Bl6 control rnice (V\IT). In 
young adult animais (Figure 3a and b), we observed retinal 
transduction near the site of injection in Rho-/- or C57/Bl6 rnice. 
Few photoreceptors were transduced in a 200 µm longitudinal 
portion of the retinal section (excluding the site of injection) of 
Rho-/- or C5 7 /B16 mouse retinas. No difference of transduction 
was observed between Rfzo-1- and \!\TT mice. In older animais (4.9 
months, Figure 3d and d'), we obtained very few transduced 
photoreceptors in Rho-/- mice and some transduction in \!\TT mice. 
To potentially reveal low GFP-expressing cells, we performed 
immunolabeling against GFP using a secondary antibody with a 
red fluorophore (Alexa633) to evidence cells not detected by GFP. 
Vve observed that red cells were also positive for GFP. In advanced 
degeneration processes (see Figure 3d), the LV-VSVG-Rhop-GFP 
vector conserved the same tropism as observed after injection into 
the normal retina, but with less efficiency. 
Another vector bearing a ubiquitous promoter, a short fragment 
of the Elongation Factor! promoter (LV-VSVG-EFs-GFP), was 
ÎI°\iected into the same mode! 1) to verify that this lack of 
photoreceptor transduction was not a problem of gene expression 
due to the health of the photoreceptors (decrease of rhodopsin 
promoter activity for instance), and 2) to determine whether other 
cell types can be reached by the vector when the OLM shows a 
disruption of the Z0-1 expression. The vector was tested in late-
stage Rho-/- degenerating retinas and in age-matched W'T 
controls. For ail animais, the largest transduced area was observed 
in the RPE layer confirming previous data showing that the 
lentiviral vector carrying a ubiquitous promoter targets mainly 
RPE cells[5,6]. The size of the transduced region of the RPE layer 
or the degenerating retinas of the Rfzo-1- mice was not different in 
comparison to normal transduced retinas (see graph in Figure 4c). 
This result shows that this vector has the same diffusion capacity in 
the wild-type or the diseased retina. Interestingly, in contrast with 
the control group, the Rfw-1- retinas contained several GFP-
positive cells in the neuroretina (but in the injection site near the 
needle tract only). \!\Te identified a significant number of GFP 
positive cells in the ONL in the transduced area of aged Rho-/-
animals (Figure 4 g, h, and i, arrows), which was unexpected in 
view of the results we obtained with the LV-VSVG-Rhop-GFP. 
This suggests that the EFs promoter is more efficient than the 
Rhodopsin promoter to drive transgene expression in the photore-
ceptors, during advanced stage of the degeneration in the Rho-1-
mice. This reduced activit:y of the Rfwdopsin promoter may be the 
consequence of the poor photoreceptor health at this stage of 
degeneration in the Rfzo-1- mouse. \!\Te also checked whether cones 
were transduced by the vector, but only a very weak expression for 
August 2011 1 Volume 6 1 Issue 8 1 e23782 
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Figure 1. The OLM is altered after light damage (LO). (a) Z0-1 is homogeneously expressed along the OLM in untreated mouse (a, arrow), 
whereas 36 hours after light damage, disruption of the protein labelling is apparent (b, arrows). Note also the reduced expression of Z0-1 after light 
damage. The slices were processed simultaneously for the immuhistochemistry labelling and pictures were taken with the same exposure time 
(700 ms). (a', b') show the nuclear staining of the respective retinas. Note that the ONL is markedly reduced in the light-damaged retina (b'). 
Representat ive pictures of wild-type mouse retina (c) and light damaged retina (d) subretinal ly injected with LV-VSVG-Rhop-GFP. Few photoreceptors 
(green) were transduced in both cases. No significant differences were observed between groups (see text). The transduced area was confined to the 
injection site. (c' and d') Merged picture of GFP expressing cel ls with DAPI staining. Calibration bar in (a): 50 µm (for a, a',b and b'). Calibration bar in 
(c): 100 µm (for c, c', d and d'). 
doi:10.1371/journal.pone.0023782.g001 
GNAT2 or RXRy was detected and rendered the co-localization 
detection problematic. Nonetheless, rare cells positive for GFP and 
GNAT2 were observed (data not shown) revealing that the EFs 
promoter is active in canes and that GFP positive cells in the ONL 
could also be canes. 
Beside these photoreceptors, some of the GFP positive cells in 
the INL have a Müller cell appearance (Figure 4d and g). To 
confirm that some glia cells were targeted, we performed 
immunolabelling for GFAP and observed certain cells expressing 
bath GFP and GFAP (Figure 4h and i). ln addition, the high 
expression level of GFAP in the Rlw-1- retina at this stage of the 
degenerating process attests of a gliosis process as previously 
described[22]. \'\Te also observed an increased GFAP immunola-
beling at the OLM level (Figure 4h and i) revealing an important 
remodeling of this membrane during the degenerating process. A 
similar gliosis was detected in the retina of another mouse mode! of 
··~· . .. 
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retinal degeneration, the Rdl mouse (Figure SI) suggesting that 
photoreceptor Joss often produces a reactive gliosis. 
Few cells in the INL with a bipolar morphology were positive 
for GFP, but not for the Go protein, normally expressed by wild-
type bipolar cells (data not shown). We attempted to investigate 
other markers, such as PK.Ca. However, a strong decrease of the 
expression ofthis protein is observed in this mode! and renders co-
localization with GFP difficult (data not shown). Other works have 
also described a reduction of PK.Ca during the retinal degener-
ation of other models [26] , probably due to a Jack of normal inputs 
from the photoreceptors. 
These results show that during the degenerating process the 
diffusion capacity of the lentiviral vector pseudotyped with the 
VSVG envelope is almost not changed. Nonetheless, we observed 
that some ]\i[üller cells can be targeted. Because a strong 
remodeling of glial cells occurs, we were interested to evaluate 
August 2011 1 Volume 6 1 Issue 8 1 e23782 
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Figure 2. Z0·1 expression in the OLM is altered in old Rho-/- mice. Z0·1 immunolabelling of wild-type (WT) retina is homogenous 
throughout the retina in 1.4, 3.3 and 5.4 month·old mice respectively (a, b, c, arrows), but the labelling changes with age. ln Rho-/-
mice, Z0-1 distribution is normal at 1 month of age (d), starts to show few alterations at 2.4 months (e, arrows) and is often disrupted at 4.9 months (f, 
arrows). (a', b', c', d', e', f') represent the nuclei of the above pictures. Note the progressive photoreceptor loss in the Rho-/- mice (d',e',f'). INL: inner 
nuclear layer, ONL: outer nuclear layer. Ali retina slices of this figure were processed simultaneously and pictures were taken with the same exposure 
time (400 ms). Calibration bar in (a): 50 µm (for ail pictures). 
doi:l 0.1371/journal.pone.0023782.g002 
Figure 3. Low photoreceptor transduction with the LV-VSVG-Rhop·GFP in the Rho-!- retina. Injections of the vector into 1.4 and 5.4 
month old wild-type (WT) retinas transduce few photoreceptors (red, a, c). Similar results were observed in the 1 month-old Rho-/- mice (b), and the 
transduction efficiency is even worse at 4.9 month (d). (a', b', c', d ') represent the nuclei (DAPI staining) of the above pictures. INL: inner nuclear layer, 
ONL: outer nuclear layer. Calibration bar in (a) 100 µm (for a, a', band b'); calibration bar in (c): 50 µm (for c, c', d and d '). 
doi:l O. 1371/journal.pone.0023782.g003 
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Figure 4. The LV-VSVG-EFs-GFP transduces cells of the inner nuclear layer and photoreceptors in the degenerating retina. ln control 
animais (5.4 months), the vector transduces cells (green) in the neuroretina only at the injected area (a, b: GFP and DAPI staining). Note that RPE cells 
are well transduced (a, b). (c) The extension of the transduced area in the neuroretina is small (left columns) both in wild-type and Rho-/- mice (n = 5 
for each group). The vector has a better efficacy on RPE cells (right columns). ln 4.9 month-old Rho-/- mice, the vector diffuses into the retina and 
targets cells with different morphologies in the INL (d, f, g, i) as well as in the ONL (g, h, i, arrows). DAPI staining of (d) and (g) are presented in (e or h). 
(f) merged pictures of (d) and (e). (h) lmmunolabelling for the Müller glial protein GFAP (red). (i) Very rare GFP-positive cells were positive for GFAP 
(red). INL: inner nuclear layer, ONL: outer nuclear layer. Calibration bar in (a): 1 OO µm (for a, b, d, e and f). Calibration bar in (g): 50 µm (for g, h and i). 
doi:l 0.1371 /journal.pone.0023782.g004 
whether an efficient gene delive1y could be achieved in these cells 
during retinal degeneration. T o optimize the transduction of 
rvlüller cells, we changed the vector envelope by replacing VSVG 
by the Mokola virus envelope. Additionally, we changed the 
promoter for the C.1vIV promoter, also shown to be active in 
J'vlüller cells[27]. Indeed, previous results performed in the brain 
have shown that Mokola-pseudotyped lentiviral vectors can 
efficiently transduce glial cells[2S,28]. Adult control and mid-
stage degeneration Rho- / - mice were injected witl1 tl1e LV-l\1ok-
CMV-GFP vector. ln the wild-type animais, the neuroretina is 
only transduced at tl1e injection site and the expression is mainly 
restricted to a large percentage of the RPE cells and en compasses 
the size of the bleb performed during the injection (Figure Sa) as 
previously described[l ,29] , tlms very similar to the VSVG 
pseudotyped LV. A large portion of the RPE layer is targeted 
by the vector. By contrast in tl1e Rho-/ - retina, the behavior of tl1e 
LV-Mok is ve1y different in comparison to LV-VSVG. The 
l\1okola vector transduces a large area of the neuroretina in tl1e 
Rho-/ - and only few cells in the \'\TT animal, 23 ±6.S % (n = S) of 
the retina surface versus l.S±0.3% (n = 4) respectively (P = 0.014, 
Figure Sc). In the diseased retina, in addition to the transduction of 
RPE cells, almost ail of the transduced cells have a Müller cell 
morphology (Figure Sd, f) and ail of the targeted cells express 
glutamine synthetase, an enzyme only expressed in this cell type 
(Figure Sh and i). We estinrnted the percentage of Müller cells 
transduced by this vector and observed that 79 ± 7. 2% (n = 3) of 
the glial cells express GFP. The extension of the transduced retina 
area is comparable to the size of tl1e RPE layer targeted by tl1e 
virus revealing the ability of the LV-Mok to target the glial cells of 
the neuroretina in a diseased retina. 
··@· •. . . 
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Discussion 
The present study shows that the lentiviral vector may have 
different capacity to transduce cells during the course of retinal 
degeneration. Indeed, retinal remodelling during the disease 
modifies the tropism of tl1e L Vs. Consequently, the use of different 
envelopes and promoters allows to play with different targets in the 
degenerating retina. Using specific Mokola-pseudotyped LV, 
Müller cells can be preferentially targeted during retinal 
degeneration along with RPE cells. 
During retinal degeneration, tl1e disruption of Z0-1 labelling 
integrity suggests that the OLM is altered rendering possible the 
ent1y of entities into the retina that are normally blocked in the 
healthy retina by this barrier. Indeed, Z0-1 is a major stabilization 
actor of the OLM connexion. In tl1e Rho-/- mice, previous studies 
showed that the decreased expression ofZ0-1 is also paralleled by 
a decrease of ~-catenin association which is normally bound to 
Z0-1 [20]. But the overall results were surprising in the late stage 
Rho- /- mice. Very few photoreceptors express GFP when using the 
LV with the Rhodopsin promo ter suggesting that the vector diffuses 
Jess in tl1e degenerating retina . However, the use of the ubiquitous 
promoter EFs shows that near the injection site some photore-
ceptors can be transduced suggesting that in the Rho-/ - mice the 
Rlwdopsin promoter activity may change during tl1e course of 
retinal degeneration or tlrnt non-detectable cones can be 
transduced. Even if some photoreceptors can be targeted with 
the LV-EFs-GFP vector, tlle number of cells that can be 
transduced remains ve1·y low. This limited photoreceptor trans-
duction is probably due to a change of OLM structure and glia 
paralleling Z0-1 expression change. 
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Figure S. ln the degenerating Rho-/- retina, the LV-Mok-CMV-GFP preferentially transduces Müller cells in an extended region of 
the retina. ln control animais (WT, 3.3 months), the vector targets cells (green) only at the injected area (a, b with DAPI). (c) The LV- Mok-CMV-GFP 
vector transduces a large portion of the Rho-/- retina but not of the wild-type retina (compare blue columns). The extension of the transduction is 
similar in the retina and the RPE layer and represents around 25-30% of the retina. ln the 2.4 month-old Rho-/- retinas, the vector infects many cells 
with a Müller morphology (d, e, f, g with DAPI). The RPE cells are not present in this picture. (f) shows a magnification of (d) to better show the Müller 
cell morphology of the transduced cells . (g) another example of transduced cells in the Rho-/- retina where both RPE cells and cells with a Müller cell 
morphology (arrow) are targeted (the brightness of RPE labelling partially hides the Müller cells). (h) many of the transduced cells express also 
glutamine synthetase (GS, red), specific of Müller cells. Few GS-positive cells do not express GFP (arrows). (i) The magnification of picture (h) reveals 
that the great majority of glutamine synthetase-positive cells were transduced. Note that few cells show no green signal in the cell body (arrow). INL: 
inner nuclear layer, ONL: outer nuclear layer, *: P=0.014. Calibration bar in (a): 100 µm (for a, b, d, e, g and h). Calibration bar in (f): represents 50 µm 
for (f) and 54 µm for (i). 
doi:l 0.1371/journal.pone.0023782.g005 
Indeed at a late stage of Rho-/ - retina degeneration, an increased 
GFAP expression was observed with many processes surrounding 
the remaining photoreceptors (see Figure 4) suggesting a transfor-
mation of the OUvI probably by reinforcing the barrier effect of the 
Müller cells endfeet. Previous studies have shown that during retinal 
degeneration, the Müller cells present a marked modification in 
protein expression [ l 7 ,2 1] , beginning to express filament protein 
such as GFAP and also vimentin that may change the structure 
density of the cells. An interesting work has demonstrated that the 
integration of primary fœtal transplanted retinal cells is drastically 
reinforced when both vin1entin and GFAP are missing in the Müller 
cells (GFAP-/-::VÎl11entin-/ - mice), whereas a reduced migration is 
seen when either GFAP or vin1entin alone is suppressed[30]. Our 
experin1ents suggest that at a later retinal degeneration stage, after 
the alteration of the Z0-1 structure, gliosis may impair VSVG-
pseudotyped lentiviral vector diffusion. 
In Rho-/ - retinas, following the defect of Z0-1 expression, some 
other components of the extracellular matrix may compensate for 
this fon ction loss. The ability of the vector to diffuse (or not) may 
thus be a question of timing during the course of OLM 
remodelling. CD44 or Neurocan are candidates of the extracel-
lular matrix (ECl\1) that may enhance the barrier effect. These 
proteoaminoglycans were shown to impair the migration of 
transplanted retinal progenitor cells from the subretinal space 
towards the retina[23]. The Crumb protein was also shown to be 
an important protein for the OLM barrier effect on transplanted 
cell integration [22]. So far, the potential barrier influence of these 
components of the ECM on viral particle diffusion is unknown and 
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merits to be investigated. Nonetheless, for certain approaches, the 
opening of this barrier seems to have to be limited in time to 
prevent retina cell alteration[3 1]. 
The lentiviral vector with the VSVG envelop was already shown to 
target l\1üller cells in the rat retina, when the vector contains the 
GFAP promoter[7]. Sw-prisingly, the presence of the CM\! promoter 
does not allow expression of the reporter transgene in Müller cells[7]. 
In this cited study, the LV-GFAPp-eGFP vector pseudotyped by the 
VSVG envelope transduces a very large proportion of l\1üller cells 
(more than 90%) when subretinally injected at PN2 l in normal and 
diseased retina (the S334T er+/ - rat which bears a dominant 
mutation in the Rlwdopsùz gene). The advantage of the LV-Mok 
vector described in our study is to target Müller cells only in a diseased 
retina, even using a ubiquitous promoter. 
Other vectors were developed to target the l\1Iüller cells such as 
Adenovirus-derived vectors. The Ad5 / F37 largely diffuses in the 
retina and transduces a round 11 % of the cells in the inner nuclear 
layer where Müller cells reside[32]. Using a directed evolution 
approach to select vectors that efficiently transduce prÎ111ate 
astrocytes in vitro, Klimczak et al. identified that the AA V variant 
ShH 10 bas a great capacity to infect Müller cells i11 vivo when 
injected into tl1e vitreous[33]. This elegant study reveals that more 
than 20% of the Müller cells can be transduced by such delive1y 
way. This variant is close to the AA2/6 serotype, which also 
specifically transduces activated Müller glia cells (but with a lower 
efficacy than the cited above serotype), when the transgene 
expression is driven by the GFAP promoter[34]. The added-value 
of these vectors and approach is to avoid deleterious sicle effects 
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with subretinal injections that are much more delicate in a 
degenerating retina. However, the delivery efficiency needs to be 
improved. 
The use of the Mokola envelope redirects the LV targeting to a 
large proportion of :tvlüller cells over an important distance 
corresponding to the bleb area (this probably through the endfeet 
which are in the vicinity of the RPE). This characteristic is seen orùy 
in the degenerating retina. This extended area of glial cell 
transduction might be interesting for using this vector for therapeutic 
applications. Indeed, targeting Müller cells may serve to deliver 
neurotrophic substances to support the surv:ival of photoreceptor 
cells during retinal degeneration. In the context of such strateg)' so 
fa r, gene transfer approaches mainly aim to target the RPE cells. 
However, a constant fluid flux from the vitreous towards the choroid 
exists. ln consequence, the t:rophic factor engineered in RPE cells is 
secreted against ù1is flux which could lin1it its efficacy. In contrast, a 
trophic factor released by Müller cells may better reach ù1e 
photoreceptors. Very interesting works recenùy demonstrated ù1e 
usefulness of this approach in two different models of retinal 
degeneration using AA V vectors(35,36]. Neurotrophic factor 
delivery may also be used in combination with gene replacement 
strateg)'. In addition, in severe forms of photoreceptor loss such as 
early forms of LCA and RP, such gene transfer can support ù1e 
survival of the photoreceptors until the benefit of the transgene 
replacement occurs[37]. Other applications of our results could be 
the contrai of the Müller cell structure to allow a better integration of 
transplanted retinal cells derived from stem cells, for instance by 
reducing gliosis, which can be achieved by siRNA t:ransfer[38]. 
l\1ost of the studies on vector tropism were undertaken in 
normal retinas or at an early stage ofretinal degeneration and little 
is known concerning the ability of the vectors to transduce retinal 
cells at advanced stages of retinal degeneration. \Ve show ùrnt the 
Mokola vector can eflicienùy transduce Müller cells in a diseased 
retina while it had been described as a very specific tool to target 
RPE cells in a normal rat retina(l ,29]. Similarly, the Rl10dopsi11 
promoter surprisingly appeared Jess efficient than the EFs 
promoter to drive transgene expression in photoreceptors in a 
degeneration context, ù1is will probably be true for any vector 
used, i. e. LV, AAV or AdV. In this regard, ù1e overall meaning of 
our results underlines the importance of evaluating gene transfer 
tools in the final context of use sin ce the environment as well as ù1e 
target cells may be subjected to various modifications that will 
impact on the transduction capacities. 
Materials and Methods 
Vector production 
The EFS-GFPII transgene cassette was obtained by subcloning 
hrGFPII (Agilent Technologies, Santa Clara, CA) in ù1e Hlox-
EFS-GFP backbone[5] after discarding the GFP gene. The Rho-
GFP transgene plasmid was described in Kostic el al.[5]. 
Production ofLV-VSV-G--Rhop or EFS-GFPII by cotransfection 
in 293T cells was performed as described in Bemelmans et al. (9]. 
The CMV-GFP cassette is described in[39]. Production of the 
Mokola-pseudotyped LV-CMV-GFP was also performed by triple 
transfection but using ù1e Mokola plasmid(29] instead of the 
pMD.G encoding the VSV-G protein. Quantifications of the 
vector stocks were measured using the RETRO-TEK HIV-! p24 
Antigen ELISA kit (ZeptoMetrixCorporation, Buffalo, NY USA) 
according to ù1e manufacturer's instructions. 
Ethic statement 
The animais were handled in accordance with the statement of 
the "Animais in Research Committee" of the Association for 
··~· . .. 
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Research in Vision and Ophilialmology, and protocols followed 
the national regulations (OFEV) and were approved by the local 
institutional committee, ù1e "Service de la consommation et des 
affaires vétérinaires du canton de Vaud" (autorisation 
VD# l 367.3). 
Animal procedure 
Rhodopsin knockout mice were de1ived from Rpe65-/-::Rho-/-
mice (Professor C. G1imm, University of Zürich) and crossed in Ùle 
C5 7 /Bl6 background. Each eye was subretinally injected with 150 ng 
of vector in 2 microliters as desciibed previously(9]. For inm1w10his-
tochemical procedures, ù1e eyes were collected 1 week after the 
ii*ction, cauterized to ii1dicate ù1e orientation, fixed in 4% 
parafmmaldehyde, washed ii1 PBS and then immerged ii1 30% 
sucrase overnight. The eye is then embedded in albwnin from ben egg 
white (Fluka, Buchs, Switzerland) and eut into 14 µm cryostat sections. 
lmmunohistochemistry 
For immunohistochemistry sections were incubated with ù1e first 
antibody overnight at 4 °C in PBS containing 0.2% TritonX-100 
and 10% normal horse serum. Sections were then washed in PBS 
and incubated with the seconda1y antibody at 37°C for l !mur. The 
following primary antibodies were used: goat polyclonal anti-GFP 
for eyes injected with LV-Rho-GFP (1/3000, Abcam), mouse 
monoclonal anti-Z0- 1 (ZO 1- IAI 2, l /60, Invitrogen , Camarilla, 
CA) and rabbit polyclonal anti-glutamine synù1etase ( l / 5000, 
Sigma-Aldrich). For visualization, fluorescence-labelled secondary 
antibodies (Alexa-488 and Alexa-633; Molecular Probes) were used. 
Sections were counterstained wiù1 DAPI (l\1olecular Probes) and 
mounted under coverslips with Mowiol 4-88 Reagent (V\VR 
International AG, Lucerne, Switzerland). 
Quantification and statistical analysis 
To evaluate the potency of the vectors to spread in the 
subretinal space and in the retina, we measured near the injection 
site tl1e maximum lengù1 of the area comprising transduced cells. 
The lengù1 of transduced RPE estimates Ùle size of the injection 
bleb while the length of transduced retina cells reflects its efliciency 
to penetrate through ù1e retinal layers. The values were expressed 
as percentage of total retinal length. If tl1e size of both transduced 
RPE and transduced retina are similar, the tested vector shows the 
capacit:y to transduce retinal cells. If the size of GFP-positive retina 
is much smaller ù1an ù1e GFP-positive RPE region, the tested 
vector penetrated into the retina only because of the injury 
produced by the needle. 
For statistical analyses, groups were compared by an unpaired 
Student T test using the Excel software (l\1icrosoft, WA). 
Supporting Information 
Figure Sl Gliosis occurs during retinal degeneration of 
the Rdl mouse retina. The mouse bears a mutation in the 
Pde6b gene leading to phototransduction inhibition and photore-
ceptor Joss. At Pl 2, GFAP (red) expression is mainly detected in 
the inner part of ù1e retina. At p 15, the gliosis increases when 
several layers of photoreceptors were already lost (compare the 
ONL size with WT retina). Magnification: 200x. 
(PDF) 
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